Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Kura Oncology Q3 EPS $(0.85) Misses $(0.84) Estimate, Sales $20.750M Miss $41.259M Estimate

Author: Benzinga Newsdesk | November 04, 2025 06:34am
Kura Oncology (NASDAQ:KURA) reported quarterly losses of $(0.85) per share which missed the analyst consensus estimate of $(0.84) by 0.59 percent. This is a 34.92 percent decrease over losses of $(0.63) per share from the same period last year. The company reported quarterly sales of $20.750 million which missed the analyst consensus estimate of $41.259 million by 49.71 percent.

Posted In: KURA


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist